FindTrial
Sign In

Pathology AI Platform

Development of Artificial Intelligence Learning Center and Pathologic Decision Support System

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003460
Enrollment
6200
Registered
2019-01-31
Start date
2018-08-08
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. histologically confirmed neuroendocrine tumor of 5 organs (liver, large intestine, prostate gland, pancreas and biliary tract, kidney) 2. patients of above diagnosis whose operative tissue or biopsy tissue is conserved in biobanks of the SNUH (Seoul National University Hospital), SNUBH (Seoul National University Bundang Hospital), SMG-SNU Boramae Medical Center 3. all cases after February 2013 with written consent forms according to relevant law and regulations such as the law about life ethics and safety

Exclusion criteria

Exclusion criteria: - cases with no or little clinical and pathologic information - cases after February 2013 without written consent forms

Design outcomes

Primary

MeasureTime frame
Areas with cancerous cells in the pathology slide image—

Countries

Korea, Republic of

Contacts

Public ContactYoo Jung Kim

Seoul National University Hospital

yjkim191@gmail.com+82-2-766-3421

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026